Skip to main content

Megan Elizabeth Bowles Clowse

Professor of Medicine
Medicine, Rheumatology and Immunology
Duke Box 3535, Durham, NC 27710
Baker House 07, Duke South, Trent Drive, Durham, NC 27710

Overview


Dr. Megan Clowse is a Professor of Medicine and Chief of the Division of Rheumatology and Immunology; she also holds joint appointments in the Department of Obstetrics and Gynecology and Population Health Sciences.  Her clinical research focuses on the management of rheumatic diseases in pregnancy. She has cared for over 1000 pregnancies in women with rheumatic disease, collecting information on these pregnancies initially in the Duke Autoimmunity in Pregnancy Registry and Repository, and the MADRA (Maternal Autoimmune Disease Research Alliance) registry and repository.  She served on the Core Leadership Team for the inaugural American College of Rheumatology's Reproductive Health Guidelines, published January 2020.  Dr. Clowse created www.LupusPregnancy.org and www.ReproRheum.Duke.edu, websites dedicated to improving pregnancy planning and management for patients and rheumatologists.  

Dr. Clowse was the founding director of the Duke Lupus Clinic, where she continues to see patients each week and mentor junior faculty researchers.  The team has developed a new approach to lupus classification and management and is currently collecting and analyzing patient- and physician-reported measures to  better clarify this construct.  


Current Duke Appointments & Affiliations


Professor of Medicine · 2024 - Present Medicine, Rheumatology and Immunology, Medicine
Professor in Population Health Sciences · 2024 - Present Population Health Sciences, Basic Science Departments
Professor in Obstetrics and Gynecology · 2024 - Present Obstetrics and Gynecology, Clinical Science Departments

Recent News Items


Published November 9, 2020
Women with Autoimmune Lung Disease Can Safely Give Birth if Closely Monitored
Published November 11, 2019
Everyday Health
Can You Breastfeed if You Have Rheumatoid Arthritis?
Published August 20, 2019
Healio Rheumatology
HOP-STEP program builds plan for 'pregnancy success' in patients with lupus

View All News Items

Recent Scholarly Works


The relationship between autoantibody and complement levels in the sera of patients with systemic lupus erythematosus.

Journal article Clin Immunol · September 25, 2026 The goal of these studies was to elucidate the relationship between levels of autoantibodies and complement (C3/C4) in the sera of patients with systemic lupus erythematosus (SLE) and thereby provide a framework for interpreting serological biomarkers in t ... Full text Link to item Cite

The Plot Thickens: From a Classic Presentation to Bilateral Renal Lesions.

Journal article Arthritis Care Res (Hoboken) · September 2026 Full text Link to item Cite

A quality improvement project to incorporate the mycophenolate Risk Evaluation and Mitigation Strategies in an academic lupus clinic

Conference Lupus · August 1, 2026 Background/Purpose: Mycophenolate compound (MMF, to represent both mycophenolate mofetil and mycophenolic acid) is an immunosuppressant used to treat Systemic Lupus Erythematosus (SLE). Due to its teratogenicity, the FDA recommends universal mycophenolate ... Full text Cite
View All Scholarly Works

Recent Grants


Azathioprine Safety and Pharmacokinetics in Pregnant Women with Rheumatic Disease and their Infants

ResearchCo Investigator · Awarded by National Institutes of Health · 2026 - 2031

2/3 CTSA K12 Program at Duke University

ResearchMentor · Awarded by National Center for Advancing Translational Sciences · 2025 - 2030

View All Grants

Education


Vanderbilt University · 1999 M.D.
University of California, Los Angeles · 1994 M.P.H.